id: NEW:dual_diagnosis_ptsd_aud_to_substance_use_treatment_dropout_rate
name: Dual Diagnosis PTSD and AUD Comorbidity â†’ Substance Use Treatment Dropout Rate
from_node:
  node_id: NEW:dual_diagnosis_ptsd_aud
  node_name: Dual Diagnosis PTSD and AUD Comorbidity
to_node:
  node_id: substance_use_treatment_dropout_rate
  node_name: Substance Use Treatment Dropout Rate
direction: positive
category: behavioral
mechanism_pathway:
- 'Step 1: Patients with comorbid PTSD and AUD present with more complex symptom profiles'
- 'Step 2: Standard treatment protocols may not adequately address both conditions simultaneously'
- 'Step 3: Increased symptom severity leads to greater treatment challenges'
- 'Step 4: Poorer treatment outcomes and higher likelihood of treatment failure or dropout'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Bo Zhan et al. 2022. "Comorbidity of Post-Traumatic Stress Disorder and Alcohol Use
    Disorder: Animal Models and Associated Neurocircuitry." https://doi.org/10.3390/ijms24010388'
  supporting_citations:
  - Additional citations require full-text access
  - Review notes poorer treatment outcomes in dual diagnosis but specific outcome studies not cited in
    abstract
  - Preclinical model development discussed as needed to improve treatment understanding
  doi: 10.3390/ijms24010388
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The abstract explicitly states that individuals with dual PTSD-AUD diagnosis 'exhibit increased
  symptom severity and poorer treatment outcomes than those with only one of these diseases.' This highlights
  the clinical challenge of treating comorbid conditions.
structural_competency:
  equity_implications: Healthcare system fragmentation between mental health and substance use treatment
    creates structural barriers to integrated care. Insurance coverage limitations, separate treatment
    facilities, and lack of cross-trained providers represent systemic failures that worsen outcomes for
    those with comorbid conditions. These structural barriers disproportionately affect populations with
    less healthcare access.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.836336'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
